Currently, CTZ has invested in several companies and projects, all within CTZ’s core business, the medical device industry.
All projects are patent protected and IP registration stage varies between the different companies.
The developer of the EBK™ procedure, a pioneering solution for ophthalmologic surgery focused on the cornea. Orca Surgical brings to market sophisticated surgical device and technologies for refractive surgery, keratoconus, refractive enhancement and treatments for recurrent erosions of the cornea. The EBK™ is an epithelium removal procedure, leaving Bowman layer intact for safer treatment and faster patient’s recovery.
TymCure Ltd. is a medical device company, developing the first device for minimally invasive trans-canal treatment of tympanic perforations. TymCure’s unique medical solution simplifies the tympanoplasty procedure dramatically, eliminating the need for surgery and general anesthesia, while providing identical results.
There is a clinical unmet need for a novel simple, rapid and safe method to position the new formatted nasal septum in position and prevent septoplasty and nasal packing complications. APHI offers an approximation device for nasal mucosa following nasal septum surgery – Combining of a needle, pusher, Nitinol inside cartridge and cutter
The company has developed and has patented a medical device for treatment and cure of bone defects such as bone infections (Osteomyelitis – OM). It is an innovative minimal-invasive, non-antibiotic method to deliver silver ions to infected area with local influence and no side effects. Also bone regeneration effect as the technology is based on a proprietary method for long term delivery of ionic silver at the targeted bone defect.
Due to the need for reducing radial artery occlusion after radial access for angioplasty, The Company develops a device for applying pressure to the radial artery to prevent bleeding while allowing blood flow amount of blood to flow through the radial artery.
Although Glaucoma is a surgical disease, current surgeries are still complex, risky, penetrating and requires unique expertise and high surgical skills. The company develops a unique shunt made of Electrospun nanofabric material in a special design which is extremely easy to place by ANY ophthalmologist. The Electrospun nanofabric material is known for its non-occluding and highly biocompatibility properties. This advantages allows Eshunt to be natural to the eye and therefore extremely safe and effective.